Clinical trial
A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)
NCT00290550 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00290550 |
|---|---|
| Title | A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006) |
| Official title | A Phase IIA Study Evaluating the Efficacy of MK0457 as a 5-Day Continuous Infusion in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | MK0457 |
| Enrollment | 22 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Feb 13, 2006 |
| Last update posted | Jul 27, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: